Meningococcal Quadrivalent (Serogroups A, C, W135 and Y) Tetanus Toxoid Conjugate Vaccine (Nimenrix™)

被引：0
|
作者：
Jamie D. Croxtall
Sohita Dhillon
机构：
[1] Adis,
来源：
Drugs | 2012年 / 72卷
关键词：
Conjugate Vaccine; Meningococcal Disease; Invasive Meningococcal Disease; Geometric Mean Titre; Meningococcal Vaccine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Nimenrix™ (MenACWY-TT) is a quadrivalent meningococcal conjugate vaccine, comprising the polysaccharide serogroups A, C, W135 and Y, and tetanus toxoid (TT) as carrier protein. It is the first quadrivalent vaccine (administered as a single dose) to be approved in Europe for active immunization of individuals aged ≥12 months against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W135 and Y.
引用
收藏
页码：2407 / 2430
页数：23
相关论文
共 50 条
  • [31] Meningococcal group A, C, Y and W-135 conjugate vaccine
    Lee H. Harrison
    Nitin Mohan
    Peter Kirkpatrick
    [J]. Nature Reviews Drug Discovery, 2010, 9 : 429 - 430
  • [32] Meningococcal group A, C, Y and W-135 conjugate vaccine
    Harrison, Lee H.
    Mohan, Nitin
    Kirkpatrick, Peter
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2010, 9 (06) : 429 - 430
  • [33] The immunogenicity and safety of an investigational meningococcal serogroups A, C, W-135, Y tetanus toxoid conjugate vaccine (ACWY-TT) compared with a licensed meningococcal tetravalent polysaccharide vaccine A randomized, controlled non-inferiority study
    Dbaibo, Ghassan
    Macalalad, Noel
    Aplasca-De Los Reyes, Mari Rose
    Dimaano, Efren
    Bianco, Veronique
    Baine, Yaela
    Miller, Jacqueline
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2012, 8 (07) : 873 - 880
  • [34] A Randomized Trial to Assess Safety and Immunogenicity of Alternative Formulations of a Quadrivalent Meningococcal (A, C, Y, and W-135) Tetanus Protein Conjugate Vaccine in Toddlers
    McVernon, Jodie
    Nolan, Terry
    Richmond, Peter
    Reynolds, Graham
    Nissen, Michael
    Lambert, Stephen B.
    Marshall, Helen
    Papa, Thomas
    Rehm, Christine
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2012, 31 (01) : E15 - E23
  • [35] Immunogenicity and Safety of a Quadrivalent Meningococcal Serogroups A, C, W-135 and Y Tetanus Toxoid Conjugate Vaccine (MenACWY-TT) Administered to Adults Aged 56 Years and Older: Results of an Open-Label, Randomized, Controlled Trial
    Dbaibo, Ghassan
    El-Ayoubi, Nabil
    Ghanem, Soha
    Hajar, Farah
    Bianco, Veronique
    Miller, Jacqueline M.
    Mesaros, Narcisa
    [J]. DRUGS & AGING, 2013, 30 (05) : 309 - 319
  • [36] Immunogenicity and Safety of a Quadrivalent Meningococcal Serogroups A, C, W-135 and Y Tetanus Toxoid Conjugate Vaccine (MenACWY-TT) Administered to Adults Aged 56 Years and Older: Results of an Open-Label, Randomized, Controlled Trial
    Ghassan Dbaibo
    Nabil El-Ayoubi
    Soha Ghanem
    Farah Hajar
    Veronique Bianco
    Jacqueline M. Miller
    Narcisa Mesaros
    [J]. Drugs & Aging, 2013, 30 : 309 - 319
  • [37] ost-effectiveness of meningococcal polysaccharide serogroups A, C, W-135 and Y conjugate vaccine in Australian adolescents
    Si, Si
    Zomer, Ella
    Fletcher, Samantha
    Lee, Jenny
    Liew, Danny
    [J]. VACCINE, 2019, 37 (35) : 5009 - 5015
  • [38] Meningococcal quadrivalent tetanus toxoid conjugate vaccine (MenACWY-TT, Nimenrix™): A review of its immunogenicity, safety, co-administration, and antibody persistence
    Assaf-Casals, Aia
    Dbaibo, Ghassan
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (07) : 1825 - 1837
  • [39] Immunogenicity and Safety of a Booster Dose of the 10-valent Pneumococcal Haemophilus Influenzae Protein D Conjugate Vaccine Coadministered With the Tetravalent Meningococcal Serogroups A, C, W-135 and Y Tetanus Toxoid Conjugate Vaccine in Toddlers: A Randomized Trial
    Ruiz-Palacios, Guillermo M.
    Huang, Li-Min
    Lin, Tzou-Yien
    Hernandez, Lorena
    Guerrero, M. Lourdes
    Villalobos, Antonio Lavalle
    Van der Wielen, Marie
    Moreira, Marta
    Fissette, Laurence
    Borys, Dorota
    Miller, Jacqueline M.
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2013, 32 (01) : 62 - 71
  • [40] Randomized trial to assess the immunogenicity, safety and antibody persistence up to three years after a single dose of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in toddlers
    Vesikari, Timo
    Forsten, Aino
    Boutriau, Dominique
    Bianco, Veronique
    Van der Wielen, Marie
    Miller, Jacqueline
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2012, 8 (12) : 1892 - 1903
12345